Evelyn Partners’s CME Group CME Stock Holding History

Evelyn Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.6M	Buy	89,989 +22,142	+33%	+$5.84M	0.38%	46
2026 Q2	$15M	Buy	+67,847	New	+$18.8M	0.03%	73

Other funds holding CME

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Evelyn Partners's CME Position: Q3 2026 in Review

Evelyn Partners increased its CME Group (CME) stake by 33% in Q3 2026, buying an estimated $5.84M and bringing the position to 89,989 shares worth $23.6M. The position accounts for 0.38% of the portfolio, ranked #46.

Evelyn Partners first reported a position in CME in Q2 2026 and has held it in 2 quarters since. 1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

Evelyn Partners held 89,989 shares of CME Group worth $23.6M as of Q3 2026.
Evelyn Partners bought 22,142 CME Group shares in Q3 2026, an estimated $5.84M.
CME Group made up 0.38% of Evelyn Partners's portfolio in Q3 2026, its #46 holding.
Evelyn Partners first reported a position in CME Group in Q2 2026 and has held it in 2 quarters since.
1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.